Evidence map›Paper›PMID 39203014›Full record

ArticleMolecules (Basel, Switzerland)2024

Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization.

Anton L Popov, Danil D Kolmanovich, Nikita N Chukavin, Ivan V Zelepukin, Gleb V Tikhonowski, Andrei I Pastukhov, Anton A Popov, Alexander E Shemyakov, Sergey M Klimentov, Vladimir A Ryabov and 3 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Polyacrylic Acid-Coated LaBPharmaceutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anton L PopovP. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, Moscow 119991, Russia.
Danil D KolmanovichP. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, Moscow 119991, Russia.ORCID 0000-0003-3391-7889
Nikita N ChukavinInstitute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 3 Institutskaya St., Pushchino 142290, Russia.ORCID 0000-0001-8431-4485
Ivan V ZelepukinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0003-0209-2116
Gleb V TikhonowskiInstitute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Kashirskoe Shosse 31, Moscow 115409, Russia.ORCID 0000-0003-4998-1631
Andrei I PastukhovLP3, CNRS, Aix-Marseille University, 13288 Marseille, France.
Anton A PopovInstitute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Kashirskoe Shosse 31, Moscow 115409, Russia.
Alexander E ShemyakovP. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, Moscow 119991, Russia.
Sergey M KlimentovInstitute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Kashirskoe Shosse 31, Moscow 115409, Russia.
Vladimir A RyabovP. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, Moscow 119991, Russia.
Sergey M DeyevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0002-3952-0631
Irina N ZavestovskayaP. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, Moscow 119991, Russia.
Andrei V KabashinLP3, CNRS, Aix-Marseille University, 13288 Marseille, France.ORCID 0000-0003-1549-7198

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boron-enhanced proton therapy has recently appeared as a promising approach to increase the efficiency of proton therapy on tumor cells, and this modality can further be improved by the use of boron nanoparticles (B NPs) as local sensitizers to achieve enhanced and targeted therapeutic outcomes. However, the mechanisms of tumor cell elimination under boron-enhanced proton therapy still require clarification. Here, we explore possible molecular mechanisms responsible for the enhancement of therapeutic outcomes under boron NP-enhanced proton therapy. Spherical B NPs with a mode size of 25 nm were prepared by methods of pulsed laser ablation in water, followed by their coating by polyethylene glycol to improve their colloidal stability in buffers. Then, we assessed the efficiency of B NPs as sensitizers of cancer cell killing under irradiation with a 160.5 MeV proton beam. Our experiments showed that the combined effect of B NPs and proton irradiation induces an increased level of superoxide anion radical generation, which leads to the depolarization of mitochondria, a drop in their membrane mitochondrial potential, and the development of apoptosis. A comprehensive gene expression analysis (via RT-PCR) confirmed increased overexpression of 52 genes (out of 87 studied) involved in the cell redox status and oxidative stress, compared to 12 genes in the cells irradiated without B NPs. Other possible mechanisms responsible for the B NPs-induced radiosensitizing effect, including one related to the generation of alpha particles, are discussed. The obtained results give a better insight into the processes involved in the boron-induced enhancement of proton therapy and enable one to optimize parameters of proton therapy in order to maximize therapeutic outcomes.

Indexed as

ApoptosisBoronNanoparticlesProton TherapyCell Line, TumorHumansMembrane Potential, MitochondrialMitochondriaNeoplasmsOxidative StressRadiation-Sensitizing AgentsBoronRadiation-Sensitizing Agentsboron nanoparticlesnanoparticle-enhanced proton therapyproton–boron capture therapyproton therapypulsed laser ablation in liquids

Identifiers

PMID39203014
PMCPMC11357428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.